SK280864B6 - Acridine derivatives, process for their preparation, and pharmaceutical compositions based thereon - Google Patents
Acridine derivatives, process for their preparation, and pharmaceutical compositions based thereon Download PDFInfo
- Publication number
- SK280864B6 SK280864B6 SK730-93A SK73093A SK280864B6 SK 280864 B6 SK280864 B6 SK 280864B6 SK 73093 A SK73093 A SK 73093A SK 280864 B6 SK280864 B6 SK 280864B6
- Authority
- SK
- Slovakia
- Prior art keywords
- dihydro
- oxo
- methyl
- phenyl
- acridinecarboxamide
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 26
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 21
- 229940027998 antiseptic and disinfectant acridine derivative Drugs 0.000 title claims abstract description 10
- 230000008569 process Effects 0.000 title claims abstract description 8
- 125000000641 acridinyl group Chemical class C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 title claims abstract 4
- 238000002360 preparation method Methods 0.000 title abstract description 7
- 150000001875 compounds Chemical class 0.000 claims abstract description 326
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 73
- 239000002246 antineoplastic agent Substances 0.000 claims abstract description 35
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 34
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 27
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 13
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 12
- 239000001301 oxygen Substances 0.000 claims abstract description 10
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract 3
- 238000002560 therapeutic procedure Methods 0.000 claims abstract 2
- 239000000203 mixture Substances 0.000 claims description 247
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 175
- -1 1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl Chemical group 0.000 claims description 170
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 claims description 120
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 54
- 229910052739 hydrogen Inorganic materials 0.000 claims description 49
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 claims description 46
- 239000001257 hydrogen Substances 0.000 claims description 44
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 41
- 150000003839 salts Chemical class 0.000 claims description 40
- 239000000126 substance Substances 0.000 claims description 34
- UWRRBLDAEWEWRC-UHFFFAOYSA-N 9-oxo-10h-acridine-4-carboxamide Chemical compound N1C2=CC=CC=C2C(=O)C2=C1C(C(=O)N)=CC=C2 UWRRBLDAEWEWRC-UHFFFAOYSA-N 0.000 claims description 30
- 239000012453 solvate Substances 0.000 claims description 28
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 27
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims description 27
- 150000002431 hydrogen Chemical class 0.000 claims description 23
- 206010028980 Neoplasm Diseases 0.000 claims description 22
- 125000000217 alkyl group Chemical group 0.000 claims description 22
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 22
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 21
- 201000011510 cancer Diseases 0.000 claims description 21
- 125000003545 alkoxy group Chemical group 0.000 claims description 20
- 150000001251 acridines Chemical class 0.000 claims description 16
- CCVDVQHIQPCZBN-UHFFFAOYSA-N 5-methoxy-9-oxo-10h-acridine-4-carboxamide Chemical compound N1C2=C(C(N)=O)C=CC=C2C(=O)C2=C1C(OC)=CC=C2 CCVDVQHIQPCZBN-UHFFFAOYSA-N 0.000 claims description 15
- 239000004480 active ingredient Substances 0.000 claims description 15
- 125000005843 halogen group Chemical group 0.000 claims description 15
- 239000002253 acid Substances 0.000 claims description 12
- 125000004414 alkyl thio group Chemical group 0.000 claims description 12
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims description 12
- 229910052717 sulfur Inorganic materials 0.000 claims description 11
- 241000124008 Mammalia Species 0.000 claims description 9
- 230000035945 sensitivity Effects 0.000 claims description 9
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 7
- 125000004434 sulfur atom Chemical group 0.000 claims description 7
- 125000001544 thienyl group Chemical group 0.000 claims description 6
- 239000013543 active substance Substances 0.000 claims description 5
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 claims description 4
- CYMHUYGZYLXSOE-UHFFFAOYSA-N 5-fluoro-9-oxo-10h-acridine-4-carboxamide Chemical compound N1C2=C(F)C=CC=C2C(=O)C2=C1C(C(=O)N)=CC=C2 CYMHUYGZYLXSOE-UHFFFAOYSA-N 0.000 claims description 4
- XRBCKNGUORSKEL-UHFFFAOYSA-N 5-methyl-9-oxo-10h-acridine-4-carboxamide Chemical compound N1C2=C(C(N)=O)C=CC=C2C(=O)C2=C1C(C)=CC=C2 XRBCKNGUORSKEL-UHFFFAOYSA-N 0.000 claims description 4
- KCBDLLNCTLQLPL-UHFFFAOYSA-N acridine-4-carboxamide Chemical compound C1=CC=C2N=C3C(C(=O)N)=CC=CC3=CC2=C1 KCBDLLNCTLQLPL-UHFFFAOYSA-N 0.000 claims description 4
- 229910052731 fluorine Inorganic materials 0.000 claims description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 claims description 3
- 125000001153 fluoro group Chemical group F* 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims description 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 2
- ZBOHWRYXWSILRQ-UHFFFAOYSA-N 5-methylsulfanyl-9-oxo-10H-acridine-4-carboxamide Chemical compound CSC1=C2NC3=C(C=CC=C3C(=O)C2=CC=C1)C(N)=O ZBOHWRYXWSILRQ-UHFFFAOYSA-N 0.000 claims description 2
- 108010092160 Dactinomycin Proteins 0.000 claims description 2
- 229930012538 Paclitaxel Natural products 0.000 claims description 2
- 229930183665 actinomycin Natural products 0.000 claims description 2
- 229930013930 alkaloid Natural products 0.000 claims description 2
- 125000003277 amino group Chemical group 0.000 claims description 2
- XCPGHVQEEXUHNC-UHFFFAOYSA-N amsacrine Chemical compound COC1=CC(NS(C)(=O)=O)=CC=C1NC1=C(C=CC=C2)C2=NC2=CC=CC=C12 XCPGHVQEEXUHNC-UHFFFAOYSA-N 0.000 claims description 2
- 229960001220 amsacrine Drugs 0.000 claims description 2
- 239000011230 binding agent Substances 0.000 claims description 2
- 150000003857 carboxamides Chemical group 0.000 claims description 2
- 229960001338 colchicine Drugs 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- KKZJGLLVHKMTCM-UHFFFAOYSA-N mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 claims description 2
- 229960001156 mitoxantrone Drugs 0.000 claims description 2
- 229960001592 paclitaxel Drugs 0.000 claims description 2
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 claims 2
- KHMNIDSQPUUKIE-UHFFFAOYSA-N CCN(C1=NC=CC2=CC=CC=C21)C(=O)C3=CC=C(C4=CC5=CC=CC=C5N=C34)C6=CC=CC=C6 Chemical compound CCN(C1=NC=CC2=CC=CC=C21)C(=O)C3=CC=C(C4=CC5=CC=CC=C5N=C34)C6=CC=CC=C6 KHMNIDSQPUUKIE-UHFFFAOYSA-N 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 229940045799 anthracyclines and related substance Drugs 0.000 claims 1
- 239000007822 coupling agent Substances 0.000 claims 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 claims 1
- 239000011593 sulfur Substances 0.000 claims 1
- 229940127089 cytotoxic agent Drugs 0.000 abstract description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 229940041181 antineoplastic drug Drugs 0.000 abstract 1
- 208000016691 refractory malignant neoplasm Diseases 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 description 423
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 317
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 266
- 239000000047 product Substances 0.000 description 216
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 201
- 239000000243 solution Substances 0.000 description 182
- 239000003921 oil Substances 0.000 description 155
- 235000019198 oils Nutrition 0.000 description 155
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 141
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 132
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 129
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 123
- 238000004458 analytical method Methods 0.000 description 119
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 93
- 235000019441 ethanol Nutrition 0.000 description 92
- 238000005481 NMR spectroscopy Methods 0.000 description 91
- 238000002425 crystallisation Methods 0.000 description 88
- 230000008025 crystallization Effects 0.000 description 88
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 84
- 239000007787 solid Substances 0.000 description 73
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 69
- 239000000706 filtrate Substances 0.000 description 61
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 57
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 56
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 45
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 45
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 42
- ZDSRKZQRHDTJCK-UHFFFAOYSA-N 5-methoxy-9-oxo-10h-acridine-4-carboxylic acid Chemical compound N1C2=C(C(O)=O)C=CC=C2C(=O)C2=C1C(OC)=CC=C2 ZDSRKZQRHDTJCK-UHFFFAOYSA-N 0.000 description 40
- 238000004440 column chromatography Methods 0.000 description 39
- 239000000284 extract Substances 0.000 description 35
- 238000010992 reflux Methods 0.000 description 35
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 33
- 239000003054 catalyst Substances 0.000 description 32
- BATAOFZEDHPRTM-UHFFFAOYSA-N 9-oxo-10h-acridine-4-carboxylic acid Chemical compound N1C2=CC=CC=C2C(=O)C2=C1C(C(=O)O)=CC=C2 BATAOFZEDHPRTM-UHFFFAOYSA-N 0.000 description 31
- 230000008878 coupling Effects 0.000 description 28
- 238000010168 coupling process Methods 0.000 description 28
- 238000005859 coupling reaction Methods 0.000 description 28
- 229910000027 potassium carbonate Inorganic materials 0.000 description 28
- 235000011181 potassium carbonates Nutrition 0.000 description 28
- 239000012044 organic layer Substances 0.000 description 26
- NWUASPKZTXJPOV-UHFFFAOYSA-N 5-fluoro-9-oxo-10h-acridine-4-carboxylic acid Chemical compound N1C2=C(F)C=CC=C2C(=O)C2=C1C(C(=O)O)=CC=C2 NWUASPKZTXJPOV-UHFFFAOYSA-N 0.000 description 24
- CEIXWJHURKEBMQ-UHFFFAOYSA-N Heliamine Chemical compound C1CNCC2=C1C=C(OC)C(OC)=C2 CEIXWJHURKEBMQ-UHFFFAOYSA-N 0.000 description 24
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 23
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 22
- 238000001953 recrystallisation Methods 0.000 description 22
- 239000000725 suspension Substances 0.000 description 22
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 21
- 238000003756 stirring Methods 0.000 description 20
- 210000004881 tumor cell Anatomy 0.000 description 19
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 18
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 17
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 16
- 239000003480 eluent Substances 0.000 description 16
- 239000012280 lithium aluminium hydride Substances 0.000 description 16
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- 239000002904 solvent Substances 0.000 description 15
- ZBJTUFBBPAZNCZ-UHFFFAOYSA-N 5-methyl-9-oxo-10h-acridine-4-carboxylic acid Chemical compound N1C2=C(C(O)=O)C=CC=C2C(=O)C2=C1C(C)=CC=C2 ZBJTUFBBPAZNCZ-UHFFFAOYSA-N 0.000 description 14
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 12
- 238000001816 cooling Methods 0.000 description 12
- 238000002329 infrared spectrum Methods 0.000 description 11
- 238000002844 melting Methods 0.000 description 11
- 230000008018 melting Effects 0.000 description 11
- 239000012074 organic phase Substances 0.000 description 11
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 239000013078 crystal Substances 0.000 description 10
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 10
- 230000009467 reduction Effects 0.000 description 10
- 238000010898 silica gel chromatography Methods 0.000 description 10
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 10
- AVDLFIONKHGQAP-UHFFFAOYSA-N 4-nitrophenoxyacetic acid Chemical compound OC(=O)COC1=CC=C([N+]([O-])=O)C=C1 AVDLFIONKHGQAP-UHFFFAOYSA-N 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 9
- 238000001914 filtration Methods 0.000 description 9
- 239000011541 reaction mixture Substances 0.000 description 9
- GDALETGZDYOOGB-UHFFFAOYSA-N Acridone Natural products C1=C(O)C=C2N(C)C3=CC=CC=C3C(=O)C2=C1O GDALETGZDYOOGB-UHFFFAOYSA-N 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- FZEYVTFCMJSGMP-UHFFFAOYSA-N acridone Chemical group C1=CC=C2C(=O)C3=CC=CC=C3NC2=C1 FZEYVTFCMJSGMP-UHFFFAOYSA-N 0.000 description 8
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 8
- 238000001665 trituration Methods 0.000 description 8
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 7
- 230000000259 anti-tumor effect Effects 0.000 description 7
- 229910052938 sodium sulfate Inorganic materials 0.000 description 7
- 235000011152 sodium sulphate Nutrition 0.000 description 7
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 7
- WUTIWOZYHHSBBU-UHFFFAOYSA-N 3-methoxy-4-nitrobenzaldehyde Chemical compound COC1=CC(C=O)=CC=C1[N+]([O-])=O WUTIWOZYHHSBBU-UHFFFAOYSA-N 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 6
- 239000003112 inhibitor Substances 0.000 description 6
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- LIBYGKUWXRBMPA-UHFFFAOYSA-N 1-(3-bromopropoxy)-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(OCCCBr)C=C1 LIBYGKUWXRBMPA-UHFFFAOYSA-N 0.000 description 5
- WQMLUHZFRFCQDB-UHFFFAOYSA-N 4-(4-nitrophenyl)butyric acid Chemical compound OC(=O)CCCC1=CC=C([N+]([O-])=O)C=C1 WQMLUHZFRFCQDB-UHFFFAOYSA-N 0.000 description 5
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 5
- 125000003118 aryl group Chemical group 0.000 description 5
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 5
- 229960004679 doxorubicin Drugs 0.000 description 5
- 230000007062 hydrolysis Effects 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- VEFLKXRACNJHOV-UHFFFAOYSA-N 1,3-dibromopropane Chemical compound BrCCCBr VEFLKXRACNJHOV-UHFFFAOYSA-N 0.000 description 4
- VZOPVJNBOQOLPN-UHFFFAOYSA-N 3-(p-nitrophenyl)propanoic acid Chemical compound OC(=O)CCC1=CC=C([N+]([O-])=O)C=C1 VZOPVJNBOQOLPN-UHFFFAOYSA-N 0.000 description 4
- LTPVSOCPYWDIFU-UHFFFAOYSA-N 4-methoxyphenylethylamine Chemical compound COC1=CC=C(CCN)C=C1 LTPVSOCPYWDIFU-UHFFFAOYSA-N 0.000 description 4
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- 241000282412 Homo Species 0.000 description 4
- BZORFPDSXLZWJF-UHFFFAOYSA-N N,N-dimethyl-1,4-phenylenediamine Chemical compound CN(C)C1=CC=C(N)C=C1 BZORFPDSXLZWJF-UHFFFAOYSA-N 0.000 description 4
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 4
- 150000008041 alkali metal carbonates Chemical class 0.000 description 4
- 239000003638 chemical reducing agent Substances 0.000 description 4
- 125000001309 chloro group Chemical group Cl* 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 239000012259 ether extract Substances 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 4
- 239000012265 solid product Substances 0.000 description 4
- 239000006188 syrup Substances 0.000 description 4
- 235000020357 syrup Nutrition 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- NJWDKABVHQLHAG-UHFFFAOYSA-N 5-nitro-9-oxo-10h-acridine-4-carboxylic acid Chemical compound N1C2=C([N+]([O-])=O)C=CC=C2C(=O)C2=C1C(C(=O)O)=CC=C2 NJWDKABVHQLHAG-UHFFFAOYSA-N 0.000 description 3
- SHOWAGCIRTUYNA-UHFFFAOYSA-N 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline;hydron;chloride Chemical compound [Cl-].C1C[NH2+]CC2=C1C=C(OC)C(OC)=C2 SHOWAGCIRTUYNA-UHFFFAOYSA-N 0.000 description 3
- ITPDYQOUSLNIHG-UHFFFAOYSA-N Amiodarone hydrochloride Chemical compound [Cl-].CCCCC=1OC2=CC=CC=C2C=1C(=O)C1=CC(I)=C(OCC[NH+](CC)CC)C(I)=C1 ITPDYQOUSLNIHG-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N DMSO Substances CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical compound CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 description 3
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 229960005260 amiodarone Drugs 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 description 3
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 3
- 229910017604 nitric acid Inorganic materials 0.000 description 3
- 229910052763 palladium Inorganic materials 0.000 description 3
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 3
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 229940079832 sodium starch glycolate Drugs 0.000 description 3
- 239000008109 sodium starch glycolate Substances 0.000 description 3
- 229920003109 sodium starch glycolate Polymers 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 235000010356 sorbitol Nutrition 0.000 description 3
- 239000012258 stirred mixture Substances 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- DIVNUTGTTIRPQA-UHFFFAOYSA-N (3,4-dimethoxyphenyl)methanamine Chemical compound COC1=CC=C(CN)C=C1OC DIVNUTGTTIRPQA-UHFFFAOYSA-N 0.000 description 2
- YBADLXQNJCMBKR-UHFFFAOYSA-N (4-nitrophenyl)acetic acid Chemical compound OC(=O)CC1=CC=C([N+]([O-])=O)C=C1 YBADLXQNJCMBKR-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- OKRLFWWHJSEZOH-UHFFFAOYSA-N 1-(3-bromopropylsulfanyl)-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(SCCCBr)C=C1 OKRLFWWHJSEZOH-UHFFFAOYSA-N 0.000 description 2
- IBYHHJPAARCAIE-UHFFFAOYSA-N 1-bromo-2-chloroethane Chemical compound ClCCBr IBYHHJPAARCAIE-UHFFFAOYSA-N 0.000 description 2
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 2
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 2
- VQFMPMDEMXCCQT-UHFFFAOYSA-N 2-(4-amino-3-methylphenyl)-n-[(3,4-dimethoxyphenyl)methyl]-n-methylacetamide Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)C(=O)CC1=CC=C(N)C(C)=C1 VQFMPMDEMXCCQT-UHFFFAOYSA-N 0.000 description 2
- FHOAJEARZZXOSR-UHFFFAOYSA-N 2-(4-aminophenyl)-n-[(3,4-dimethoxyphenyl)methyl]-n-methylacetamide Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)C(=O)CC1=CC=C(N)C=C1 FHOAJEARZZXOSR-UHFFFAOYSA-N 0.000 description 2
- GYXAPUUDUHBTSB-UHFFFAOYSA-N 2-(4-methoxy-3-nitrophenyl)acetic acid Chemical compound COC1=CC=C(CC(O)=O)C=C1[N+]([O-])=O GYXAPUUDUHBTSB-UHFFFAOYSA-N 0.000 description 2
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 2
- PBIDRTDEJPAXHY-UHFFFAOYSA-N 2-iodobenzene-1,3-dicarboxylic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1I PBIDRTDEJPAXHY-UHFFFAOYSA-N 0.000 description 2
- KFXPJGCQZVOKPH-UHFFFAOYSA-N 2-methylsulfanyl-9-oxo-10H-acridine-4-carboxamide Chemical compound CSC1=CC=2C(C3=CC=CC=C3NC=2C(=C1)C(=O)N)=O KFXPJGCQZVOKPH-UHFFFAOYSA-N 0.000 description 2
- DNVDXYKLHMOMBT-UHFFFAOYSA-N 2-methylsulfanyl-9-oxo-10h-acridine-4-carboxylic acid Chemical compound C1=CC=C2C(=O)C3=CC(SC)=CC(C(O)=O)=C3NC2=C1 DNVDXYKLHMOMBT-UHFFFAOYSA-N 0.000 description 2
- SYBYTAAJFKOIEJ-UHFFFAOYSA-N 3-Methylbutan-2-one Chemical compound CC(C)C(C)=O SYBYTAAJFKOIEJ-UHFFFAOYSA-N 0.000 description 2
- AFSZUTLUNQVPJG-UHFFFAOYSA-N 4-[2-[(3,4-dimethoxyphenyl)methyl-methylamino]ethoxy]aniline Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)CCOC1=CC=C(N)C=C1 AFSZUTLUNQVPJG-UHFFFAOYSA-N 0.000 description 2
- FULPLDXWPCLVCD-UHFFFAOYSA-N 4-[3-[(3,4-dimethoxyphenyl)methyl-methylamino]propyl]-2-methoxyaniline Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)CCCC1=CC=C(N)C(OC)=C1 FULPLDXWPCLVCD-UHFFFAOYSA-N 0.000 description 2
- BOYMKERYLXDCHJ-UHFFFAOYSA-N 5,8-dimethoxy-9-oxo-10h-acridine-4-carboxylic acid Chemical compound N1C2=C(C(O)=O)C=CC=C2C(=O)C2=C1C(OC)=CC=C2OC BOYMKERYLXDCHJ-UHFFFAOYSA-N 0.000 description 2
- MVJFPALZSSSBDX-UHFFFAOYSA-N 5-methylsulfanyl-9-oxo-10h-acridine-4-carboxylic acid Chemical compound N1C2=C(C(O)=O)C=CC=C2C(=O)C2=C1C(SC)=CC=C2 MVJFPALZSSSBDX-UHFFFAOYSA-N 0.000 description 2
- DTNCSEICKBDBTF-UHFFFAOYSA-N 5-nitro-9-oxo-10H-acridine-4-carboxamide Chemical compound [N+](=O)([O-])C1=C2NC=3C(=CC=CC=3C(C2=CC=C1)=O)C(=O)N DTNCSEICKBDBTF-UHFFFAOYSA-N 0.000 description 2
- FBUPEJPJEDDTEX-UHFFFAOYSA-N 7-methoxy-9-oxo-10H-acridine-4-carboxamide Chemical compound COC1=CC=C2NC=3C(=CC=CC=3C(C2=C1)=O)C(=O)N FBUPEJPJEDDTEX-UHFFFAOYSA-N 0.000 description 2
- SANFCNGEEZLMQC-UHFFFAOYSA-N 7-methoxy-9-oxo-10h-acridine-4-carboxylic acid Chemical compound C1=CC=C2C(=O)C3=CC(OC)=CC=C3NC2=C1C(O)=O SANFCNGEEZLMQC-UHFFFAOYSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical class CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 101150065749 Churc1 gene Proteins 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 2
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- JCMWSVNNSPUNER-UHFFFAOYSA-N N,O-dimethyltyramine Chemical compound CNCCC1=CC=C(OC)C=C1 JCMWSVNNSPUNER-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 102100038239 Protein Churchill Human genes 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000007239 Wittig reaction Methods 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- XXTZHYXQVWRADW-UHFFFAOYSA-N diazomethanone Chemical compound [N]N=C=O XXTZHYXQVWRADW-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- IIEWJVIFRVWJOD-UHFFFAOYSA-N ethyl cyclohexane Natural products CCC1CCCCC1 IIEWJVIFRVWJOD-UHFFFAOYSA-N 0.000 description 2
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 150000008282 halocarbons Chemical class 0.000 description 2
- 230000002140 halogenating effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 125000006533 methyl amino methyl group Chemical group [H]N(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
- MFMAAHVPYVBFOA-UHFFFAOYSA-N n-[4-[3-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)propyl]-2-methoxyphenyl]-5-fluoro-9-oxo-10h-acridine-4-carboxamide Chemical compound N1C2=C(F)C=CC=C2C(=O)C2=C1C(C(=O)NC1=CC=C(CCCN3CC4=CC(OC)=C(OC)C=C4CC3)C=C1OC)=CC=C2 MFMAAHVPYVBFOA-UHFFFAOYSA-N 0.000 description 2
- HVAAHUDGWQAAOJ-UHFFFAOYSA-N n-benzylethanamine Chemical compound CCNCC1=CC=CC=C1 HVAAHUDGWQAAOJ-UHFFFAOYSA-N 0.000 description 2
- YGDVLXUWGVDHAV-UHFFFAOYSA-N n-methyl-1-(4-methylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=C(SC)C=C1 YGDVLXUWGVDHAV-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- IPOVLZSJBYKHHU-UHFFFAOYSA-N piperidin-3-ylmethanamine Chemical compound NCC1CCCNC1 IPOVLZSJBYKHHU-UHFFFAOYSA-N 0.000 description 2
- 239000012254 powdered material Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 229910001923 silver oxide Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- 229960001722 verapamil Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000008215 water for injection Substances 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- IIFVWLUQBAIPMJ-UHFFFAOYSA-N (4-fluorophenyl)methanamine Chemical compound NCC1=CC=C(F)C=C1 IIFVWLUQBAIPMJ-UHFFFAOYSA-N 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- HBOBUTXJMIXYPE-UHFFFAOYSA-N 1,2-bis(chloromethyl)-4,5-dimethoxybenzene Chemical compound COC1=CC(CCl)=C(CCl)C=C1OC HBOBUTXJMIXYPE-UHFFFAOYSA-N 0.000 description 1
- FPIGOBKNDYAZTP-UHFFFAOYSA-N 1,2-epoxy-3-(4-nitrophenoxy)propane Chemical compound C1=CC([N+](=O)[O-])=CC=C1OCC1OC1 FPIGOBKNDYAZTP-UHFFFAOYSA-N 0.000 description 1
- XQODFBIAQVJQHF-UHFFFAOYSA-N 1-(3,4-dimethoxyphenyl)-n-methylmethanamine Chemical compound CNCC1=CC=C(OC)C(OC)=C1 XQODFBIAQVJQHF-UHFFFAOYSA-N 0.000 description 1
- PMAHGRZCIBFEOX-UHFFFAOYSA-N 1-(3-bromopropoxy)-3-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC(OCCCBr)=C1 PMAHGRZCIBFEOX-UHFFFAOYSA-N 0.000 description 1
- SXYLTLZARIMRRU-UHFFFAOYSA-N 1-(3-chloroprop-1-enyl)-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(C=CCCl)C=C1 SXYLTLZARIMRRU-UHFFFAOYSA-N 0.000 description 1
- GTNVWVLCXAHTCJ-UHFFFAOYSA-N 1-(4-bromobutyl)-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(CCCCBr)C=C1 GTNVWVLCXAHTCJ-UHFFFAOYSA-N 0.000 description 1
- KRLZPECRWPTVJR-UHFFFAOYSA-N 1-(4-chlorobut-2-enyl)-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(CC=CCCl)C=C1 KRLZPECRWPTVJR-UHFFFAOYSA-N 0.000 description 1
- SZJIQLSCDIEJFC-UHFFFAOYSA-N 1-(4-fluorophenyl)-n-methylmethanamine Chemical compound CNCC1=CC=C(F)C=C1 SZJIQLSCDIEJFC-UHFFFAOYSA-N 0.000 description 1
- JATNRBHGAKYFMG-UHFFFAOYSA-N 1-(4-nitrophenoxy)propan-2-ol Chemical compound CC(O)COC1=CC=C([N+]([O-])=O)C=C1 JATNRBHGAKYFMG-UHFFFAOYSA-N 0.000 description 1
- RHAGOMIMRYPSHQ-UHFFFAOYSA-N 1-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-2-(3-methyl-4-nitrophenyl)ethanone Chemical compound C1C=2C=C(OC)C(OC)=CC=2CCN1C(=O)CC1=CC=C([N+]([O-])=O)C(C)=C1 RHAGOMIMRYPSHQ-UHFFFAOYSA-N 0.000 description 1
- SOSANADIJCUBJM-UHFFFAOYSA-N 1-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-2-(4-nitrophenoxy)ethanone Chemical compound C1C=2C=C(OC)C(OC)=CC=2CCN1C(=O)COC1=CC=C([N+]([O-])=O)C=C1 SOSANADIJCUBJM-UHFFFAOYSA-N 0.000 description 1
- JRDCGESNTUBLHY-UHFFFAOYSA-N 1-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-3-(3-methoxy-4-nitrophenyl)prop-2-en-1-one Chemical compound C1C=2C=C(OC)C(OC)=CC=2CCN1C(=O)C=CC1=CC=C([N+]([O-])=O)C(OC)=C1 JRDCGESNTUBLHY-UHFFFAOYSA-N 0.000 description 1
- BRIOVKGXDPBSDP-UHFFFAOYSA-N 1-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-3-(4-nitrophenyl)propan-1-one Chemical compound C1C=2C=C(OC)C(OC)=CC=2CCN1C(=O)CCC1=CC=C([N+]([O-])=O)C=C1 BRIOVKGXDPBSDP-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- HMEYGXRBYUGKPP-UHFFFAOYSA-N 1-bromo-2-(4-nitrophenyl)benzene Chemical compound C1=CC([N+](=O)[O-])=CC=C1C1=CC=CC=C1Br HMEYGXRBYUGKPP-UHFFFAOYSA-N 0.000 description 1
- PJUPKRYGDFTMTM-UHFFFAOYSA-N 1-hydroxybenzotriazole;hydrate Chemical compound O.C1=CC=C2N(O)N=NC2=C1 PJUPKRYGDFTMTM-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- YYNJPEUTZDLSGJ-UHFFFAOYSA-N 10-methyl-9-oxoacridine-4-carboxamide Chemical compound CN1C=2C(=CC=CC=2C(C2=CC=CC=C12)=O)C(=O)N YYNJPEUTZDLSGJ-UHFFFAOYSA-N 0.000 description 1
- SRSLCIOFFNJQBB-UHFFFAOYSA-N 10-methyl-9-oxoacridine-4-carboxylic acid Chemical compound C1=CC(C(O)=O)=C2N(C)C3=CC=CC=C3C(=O)C2=C1 SRSLCIOFFNJQBB-UHFFFAOYSA-N 0.000 description 1
- LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 1
- GEQNZVKIDIPGCO-UHFFFAOYSA-N 2,4-dimethoxyaniline Chemical compound COC1=CC=C(N)C(OC)=C1 GEQNZVKIDIPGCO-UHFFFAOYSA-N 0.000 description 1
- IJILAQWYAMFKOM-UHFFFAOYSA-N 2-(2-carboxyanilino)-5-methylsulfanylbenzoic acid Chemical compound OC(=O)C1=CC(SC)=CC=C1NC1=CC=CC=C1C(O)=O IJILAQWYAMFKOM-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- HNJWKRMESUMDQE-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-n-methylethanamine Chemical compound CNCCC1=CC=C(OC)C(OC)=C1 HNJWKRMESUMDQE-UHFFFAOYSA-N 0.000 description 1
- OCLMBUYLPBCFAD-UHFFFAOYSA-N 2-(3-amino-4-methoxyphenyl)-1-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)ethanone Chemical compound C1=C(N)C(OC)=CC=C1CC(=O)N1CC2=CC(OC)=C(OC)C=C2CC1 OCLMBUYLPBCFAD-UHFFFAOYSA-N 0.000 description 1
- CWAJOYCYODQOML-UHFFFAOYSA-N 2-(3-methoxy-4-nitrophenyl)acetic acid Chemical compound COC1=CC(CC(O)=O)=CC=C1[N+]([O-])=O CWAJOYCYODQOML-UHFFFAOYSA-N 0.000 description 1
- NUYOXESWWGUDLP-UHFFFAOYSA-N 2-(3-methyl-4-nitrophenyl)acetic acid Chemical compound CC1=CC(CC(O)=O)=CC=C1[N+]([O-])=O NUYOXESWWGUDLP-UHFFFAOYSA-N 0.000 description 1
- AUNJYBPXPZQREY-UHFFFAOYSA-N 2-(4-amino-3-methoxyphenyl)-n-[(3,4-dimethoxyphenyl)methyl]-n-methylacetamide Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)C(=O)CC1=CC=C(N)C(OC)=C1 AUNJYBPXPZQREY-UHFFFAOYSA-N 0.000 description 1
- BMFJMORCSZJVEA-UHFFFAOYSA-N 2-(4-aminophenoxy)-1-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)ethanone Chemical compound C1C=2C=C(OC)C(OC)=CC=2CCN1C(=O)COC1=CC=C(N)C=C1 BMFJMORCSZJVEA-UHFFFAOYSA-N 0.000 description 1
- BXZDZVQSXRIADG-UHFFFAOYSA-N 2-(4-aminophenoxy)-n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methylacetamide Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)C(=O)COC1=CC=C(N)C=C1 BXZDZVQSXRIADG-UHFFFAOYSA-N 0.000 description 1
- UKXBBDHJJDNNMA-UHFFFAOYSA-N 2-(4-aminophenoxy)-n-[2-(4-methoxyphenyl)ethyl]-n-methylacetamide Chemical compound C1=CC(OC)=CC=C1CCN(C)C(=O)COC1=CC=C(N)C=C1 UKXBBDHJJDNNMA-UHFFFAOYSA-N 0.000 description 1
- DCCGZZLYKBQOEW-UHFFFAOYSA-N 2-(4-aminophenoxy)-n-methyl-n-[(4-methylphenyl)methyl]acetamide Chemical compound C=1C=C(N)C=CC=1OCC(=O)N(C)CC1=CC=C(C)C=C1 DCCGZZLYKBQOEW-UHFFFAOYSA-N 0.000 description 1
- HOXJNQSPRGSHNF-UHFFFAOYSA-N 2-(4-aminophenyl)-n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methylacetamide Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)C(=O)CC1=CC=C(N)C=C1 HOXJNQSPRGSHNF-UHFFFAOYSA-N 0.000 description 1
- HLPIUMAGCKSZKH-UHFFFAOYSA-N 2-(4-aminophenyl)sulfanyl-n-[(3,4-dimethoxyphenyl)methyl]-n-methylacetamide Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)C(=O)CSC1=CC=C(N)C=C1 HLPIUMAGCKSZKH-UHFFFAOYSA-N 0.000 description 1
- FLUYDOVOMDZUEV-UHFFFAOYSA-N 2-(4-nitrophenoxy)acetyl chloride Chemical compound [O-][N+](=O)C1=CC=C(OCC(Cl)=O)C=C1 FLUYDOVOMDZUEV-UHFFFAOYSA-N 0.000 description 1
- HHAYDWNLYGDHJN-UHFFFAOYSA-N 2-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-1-(4-nitrophenyl)ethanol Chemical compound C1C=2C=C(OC)C(OC)=CC=2CCN1CC(O)C1=CC=C([N+]([O-])=O)C=C1 HHAYDWNLYGDHJN-UHFFFAOYSA-N 0.000 description 1
- NMMBMHSQZGLSHD-UHFFFAOYSA-N 2-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-1-(4-nitrophenyl)ethanone;hydrobromide Chemical compound Br.C1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)C1=CC=C([N+]([O-])=O)C=C1 NMMBMHSQZGLSHD-UHFFFAOYSA-N 0.000 description 1
- WBHGTFXMXOWKQS-UHFFFAOYSA-N 2-[(3,4-dimethoxyphenyl)methyl-methylamino]-n-(4-nitrophenyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)CC(=O)NC1=CC=C([N+]([O-])=O)C=C1 WBHGTFXMXOWKQS-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- MBUPVGIGAMCMBT-UHFFFAOYSA-N 2-bromo-1-(4-nitrophenyl)ethanone Chemical compound [O-][N+](=O)C1=CC=C(C(=O)CBr)C=C1 MBUPVGIGAMCMBT-UHFFFAOYSA-N 0.000 description 1
- BGMUNQSBDGBWIN-UHFFFAOYSA-N 2-bromo-n-methyl-n-[(4-nitrophenyl)methyl]acetamide Chemical compound BrCC(=O)N(C)CC1=CC=C([N+]([O-])=O)C=C1 BGMUNQSBDGBWIN-UHFFFAOYSA-N 0.000 description 1
- LSTRKXWIZZZYAS-UHFFFAOYSA-N 2-bromoacetyl bromide Chemical compound BrCC(Br)=O LSTRKXWIZZZYAS-UHFFFAOYSA-N 0.000 description 1
- HJDZJDJRUVAYTR-UHFFFAOYSA-N 2-chloro-5-methylsulfanylbenzoic acid Chemical compound CSC1=CC=C(Cl)C(C(O)=O)=C1 HJDZJDJRUVAYTR-UHFFFAOYSA-N 0.000 description 1
- AZURFBCEYQYATI-UHFFFAOYSA-N 2-chloro-n-(4-nitrophenyl)acetamide Chemical compound [O-][N+](=O)C1=CC=C(NC(=O)CCl)C=C1 AZURFBCEYQYATI-UHFFFAOYSA-N 0.000 description 1
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 1
- IQUPABOKLQSFBK-UHFFFAOYSA-N 2-nitrophenol Chemical class OC1=CC=CC=C1[N+]([O-])=O IQUPABOKLQSFBK-UHFFFAOYSA-N 0.000 description 1
- XEFRNCLPPFDWAC-UHFFFAOYSA-N 3,4,5-trimethoxyaniline Chemical compound COC1=CC(N)=CC(OC)=C1OC XEFRNCLPPFDWAC-UHFFFAOYSA-N 0.000 description 1
- 125000005809 3,4,5-trimethoxyphenyl group Chemical group [H]C1=C(OC([H])([H])[H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 1
- ANOUKFYBOAKOIR-UHFFFAOYSA-N 3,4-dimethoxyphenylethylamine Chemical compound COC1=CC=C(CCN)C=C1OC ANOUKFYBOAKOIR-UHFFFAOYSA-N 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- APWYSNXRLWQKRK-UHFFFAOYSA-N 3-(3-aminophenyl)-1-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)propan-1-one Chemical compound C1C=2C=C(OC)C(OC)=CC=2CCN1C(=O)CCC1=CC=CC(N)=C1 APWYSNXRLWQKRK-UHFFFAOYSA-N 0.000 description 1
- SLLKZGGBSDQPPV-UHFFFAOYSA-N 3-(3-ethoxy-4-nitrophenyl)prop-2-enoic acid Chemical compound CCOC1=CC(C=CC(O)=O)=CC=C1[N+]([O-])=O SLLKZGGBSDQPPV-UHFFFAOYSA-N 0.000 description 1
- REJOBCUTAMAPIS-UHFFFAOYSA-N 3-(3-methoxy-4-nitrophenyl)prop-2-enoic acid Chemical compound COC1=CC(C=CC(O)=O)=CC=C1[N+]([O-])=O REJOBCUTAMAPIS-UHFFFAOYSA-N 0.000 description 1
- PXSHHXYFJBQESV-UHFFFAOYSA-N 3-(3-methyl-4-nitrophenyl)propanoic acid Chemical compound CC1=CC(CCC(O)=O)=CC=C1[N+]([O-])=O PXSHHXYFJBQESV-UHFFFAOYSA-N 0.000 description 1
- BCAZGGXXCLKBNR-UHFFFAOYSA-N 3-(4-amino-3-methylphenyl)-n-[(3,4-dimethoxyphenyl)methyl]-n-methylpropanamide Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)C(=O)CCC1=CC=C(N)C(C)=C1 BCAZGGXXCLKBNR-UHFFFAOYSA-N 0.000 description 1
- YMDRYIMADHLIEB-UHFFFAOYSA-N 3-(4-aminophenyl)-1-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)propan-1-one Chemical compound C1C=2C=C(OC)C(OC)=CC=2CCN1C(=O)CCC1=CC=C(N)C=C1 YMDRYIMADHLIEB-UHFFFAOYSA-N 0.000 description 1
- PSGSCHGZHTUGOZ-UHFFFAOYSA-N 3-(4-aminophenyl)-n-[(3,4-dimethoxyphenyl)methyl]-n-methylpropanamide Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)C(=O)CCC1=CC=C(N)C=C1 PSGSCHGZHTUGOZ-UHFFFAOYSA-N 0.000 description 1
- YLDBSJIAMIITCT-UHFFFAOYSA-N 3-(4-aminophenyl)-n-[(4-methoxyphenyl)methyl]-n-methylpropanamide Chemical compound C1=CC(OC)=CC=C1CN(C)C(=O)CCC1=CC=C(N)C=C1 YLDBSJIAMIITCT-UHFFFAOYSA-N 0.000 description 1
- OHVRZGFPJVFYCC-UHFFFAOYSA-N 3-(4-aminophenyl)-n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methylpropanamide Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)C(=O)CCC1=CC=C(N)C=C1 OHVRZGFPJVFYCC-UHFFFAOYSA-N 0.000 description 1
- JMXNSVKCJGLNFE-UHFFFAOYSA-N 3-[2-[(3,4-dimethoxyphenyl)methyl-methylamino]ethyl]aniline Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)CCC1=CC=CC(N)=C1 JMXNSVKCJGLNFE-UHFFFAOYSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- IEVLFKKQINSPRO-UHFFFAOYSA-N 3-[3-[(3,4-dimethoxyphenyl)methyl-methylamino]propoxy]aniline Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)CCCOC1=CC=CC(N)=C1 IEVLFKKQINSPRO-UHFFFAOYSA-N 0.000 description 1
- SHWNKUXEEOMGHN-UHFFFAOYSA-N 3-[3-[(3,4-dimethoxyphenyl)methyl-methylamino]propyl]aniline Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)CCCC1=CC=CC(N)=C1 SHWNKUXEEOMGHN-UHFFFAOYSA-N 0.000 description 1
- DKTRZBWXGOPYIX-UHFFFAOYSA-N 3-chloro-4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C(Cl)=C1 DKTRZBWXGOPYIX-UHFFFAOYSA-N 0.000 description 1
- HORNXRXVQWOLPJ-UHFFFAOYSA-N 3-chlorophenol Chemical compound OC1=CC=CC(Cl)=C1 HORNXRXVQWOLPJ-UHFFFAOYSA-N 0.000 description 1
- URRALPANRJHSQK-UHFFFAOYSA-N 3-ethyl-4-nitrophenol Chemical compound CCC1=CC(O)=CC=C1[N+]([O-])=O URRALPANRJHSQK-UHFFFAOYSA-N 0.000 description 1
- AUBBVPIQUDFRQI-UHFFFAOYSA-N 3-hydroxy-4-nitrobenzaldehyde Chemical compound OC1=CC(C=O)=CC=C1[N+]([O-])=O AUBBVPIQUDFRQI-UHFFFAOYSA-N 0.000 description 1
- AHYDCPUKEAXCKZ-UHFFFAOYSA-M 3-hydroxypropyl(triphenyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(CCCO)C1=CC=CC=C1 AHYDCPUKEAXCKZ-UHFFFAOYSA-M 0.000 description 1
- CCPUOOUROHGAOD-UHFFFAOYSA-N 3-methoxy-4-nitrobenzoyl chloride Chemical compound COC1=CC(C(Cl)=O)=CC=C1[N+]([O-])=O CCPUOOUROHGAOD-UHFFFAOYSA-N 0.000 description 1
- DUEGOHNPUBPUIV-UHFFFAOYSA-N 3-methyl-4-nitrobenzoyl chloride Chemical compound CC1=CC(C(Cl)=O)=CC=C1[N+]([O-])=O DUEGOHNPUBPUIV-UHFFFAOYSA-N 0.000 description 1
- AMSJBNMFXXARTQ-UHFFFAOYSA-N 3406-75-5 Chemical compound OC(=O)CSC1=CC=C([N+]([O-])=O)C=C1 AMSJBNMFXXARTQ-UHFFFAOYSA-N 0.000 description 1
- LNPMZQXEPNWCMG-UHFFFAOYSA-N 4-(2-aminoethyl)aniline Chemical compound NCCC1=CC=C(N)C=C1 LNPMZQXEPNWCMG-UHFFFAOYSA-N 0.000 description 1
- CQLILHSHXUWDMD-UHFFFAOYSA-N 4-(3-bromopropoxy)-2-ethyl-1-nitrobenzene Chemical compound CCC1=CC(OCCCBr)=CC=C1[N+]([O-])=O CQLILHSHXUWDMD-UHFFFAOYSA-N 0.000 description 1
- LYLSNCBOQNRIIQ-UHFFFAOYSA-N 4-(3-bromopropoxy)-2-methoxy-1-nitrobenzene Chemical compound COC1=CC(OCCCBr)=CC=C1[N+]([O-])=O LYLSNCBOQNRIIQ-UHFFFAOYSA-N 0.000 description 1
- PSLJJVMBIUVRLB-UHFFFAOYSA-N 4-(3-bromopropoxy)-2-methyl-1-nitrobenzene Chemical compound CC1=CC(OCCCBr)=CC=C1[N+]([O-])=O PSLJJVMBIUVRLB-UHFFFAOYSA-N 0.000 description 1
- MEJDIEQCJKKKDY-UHFFFAOYSA-N 4-(3-bromopropoxy)aniline Chemical compound NC1=CC=C(OCCCBr)C=C1 MEJDIEQCJKKKDY-UHFFFAOYSA-N 0.000 description 1
- XARDIENSGLXTKJ-UHFFFAOYSA-N 4-(3-methoxy-4-nitrophenyl)but-3-en-1-ol Chemical compound COC1=CC(C=CCCO)=CC=C1[N+]([O-])=O XARDIENSGLXTKJ-UHFFFAOYSA-N 0.000 description 1
- VJZCMUZZIVFKGD-UHFFFAOYSA-N 4-(4-aminophenyl)-n-[(3,4-dimethoxyphenyl)methyl]-n-methylbutanamide Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)C(=O)CCCC1=CC=C(N)C=C1 VJZCMUZZIVFKGD-UHFFFAOYSA-N 0.000 description 1
- AWRCFHKIPWBTNP-UHFFFAOYSA-N 4-(4-aminophenyl)-n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methylbutanamide Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)C(=O)CCCC1=CC=C(N)C=C1 AWRCFHKIPWBTNP-UHFFFAOYSA-N 0.000 description 1
- YDTCUHSIOXTFLL-UHFFFAOYSA-N 4-(4-aminophenyl)-n-[2-(4-methoxyphenyl)ethyl]-n-methylbutanamide Chemical compound C1=CC(OC)=CC=C1CCN(C)C(=O)CCCC1=CC=C(N)C=C1 YDTCUHSIOXTFLL-UHFFFAOYSA-N 0.000 description 1
- WOUWGCLQOJPWHS-UHFFFAOYSA-N 4-(bromomethyl)-2-methyl-1-nitrobenzene Chemical compound CC1=CC(CBr)=CC=C1[N+]([O-])=O WOUWGCLQOJPWHS-UHFFFAOYSA-N 0.000 description 1
- KGVSZGUBQUXNSY-UHFFFAOYSA-N 4-[2-[(4-methoxyphenyl)methyl-methylamino]ethoxy]aniline Chemical compound C1=CC(OC)=CC=C1CN(C)CCOC1=CC=C(N)C=C1 KGVSZGUBQUXNSY-UHFFFAOYSA-N 0.000 description 1
- ULXMOMOHYKBNHH-UHFFFAOYSA-N 4-[2-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]ethoxy]aniline Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCOC1=CC=C(N)C=C1 ULXMOMOHYKBNHH-UHFFFAOYSA-N 0.000 description 1
- SLOXDZDOMBNDOK-UHFFFAOYSA-N 4-[2-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]ethyl]aniline Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCC1=CC=C(N)C=C1 SLOXDZDOMBNDOK-UHFFFAOYSA-N 0.000 description 1
- WTCYRDGERVQFMP-UHFFFAOYSA-N 4-[2-[2-(4-methoxyphenyl)ethyl-methylamino]ethoxy]aniline Chemical compound C1=CC(OC)=CC=C1CCN(C)CCOC1=CC=C(N)C=C1 WTCYRDGERVQFMP-UHFFFAOYSA-N 0.000 description 1
- OKHNWIUOEQTSLY-UHFFFAOYSA-N 4-[2-[2-(4-methoxyphenyl)ethyl-methylamino]ethyl]aniline Chemical compound C1=CC(OC)=CC=C1CCN(C)CCC1=CC=C(N)C=C1 OKHNWIUOEQTSLY-UHFFFAOYSA-N 0.000 description 1
- RVWJWJPSXCYYOD-UHFFFAOYSA-N 4-[2-[benzyl(ethyl)amino]ethoxy]aniline Chemical compound C=1C=CC=CC=1CN(CC)CCOC1=CC=C(N)C=C1 RVWJWJPSXCYYOD-UHFFFAOYSA-N 0.000 description 1
- VQAWOAHMJCDEGE-UHFFFAOYSA-N 4-[2-[benzyl(methyl)amino]ethoxy]aniline Chemical compound C=1C=CC=CC=1CN(C)CCOC1=CC=C(N)C=C1 VQAWOAHMJCDEGE-UHFFFAOYSA-N 0.000 description 1
- WJCLGSVTSWGWKG-UHFFFAOYSA-N 4-[2-[methyl-[(4-methylphenyl)methyl]amino]ethoxy]aniline Chemical compound C=1C=C(C)C=CC=1CN(C)CCOC1=CC=C(N)C=C1 WJCLGSVTSWGWKG-UHFFFAOYSA-N 0.000 description 1
- YXWKJSFDOUNFBL-UHFFFAOYSA-N 4-[2-[methyl-[(4-methylsulfanylphenyl)methyl]amino]ethoxy]aniline Chemical compound C1=CC(SC)=CC=C1CN(C)CCOC1=CC=C(N)C=C1 YXWKJSFDOUNFBL-UHFFFAOYSA-N 0.000 description 1
- OLNUVZQOICTPBI-UHFFFAOYSA-N 4-[3-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)propoxy]-2-methoxyaniline Chemical compound C1=C(N)C(OC)=CC(OCCCN2CC3=CC(OC)=C(OC)C=C3CC2)=C1 OLNUVZQOICTPBI-UHFFFAOYSA-N 0.000 description 1
- BZSPICYMEKBHLJ-UHFFFAOYSA-N 4-[3-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)propoxy]-2-methylaniline Chemical compound C1C=2C=C(OC)C(OC)=CC=2CCN1CCCOC1=CC=C(N)C(C)=C1 BZSPICYMEKBHLJ-UHFFFAOYSA-N 0.000 description 1
- DDYFVVHUIPFHBH-UHFFFAOYSA-N 4-[3-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)propyl]-2-ethoxyaniline Chemical compound C1=C(N)C(OCC)=CC(CCCN2CC3=CC(OC)=C(OC)C=C3CC2)=C1 DDYFVVHUIPFHBH-UHFFFAOYSA-N 0.000 description 1
- CWMDTTATVCLRLI-UHFFFAOYSA-N 4-[3-[(3,4-dimethoxyphenyl)methyl-methylamino]propoxy]-2-ethylaniline Chemical compound C1=C(N)C(CC)=CC(OCCCN(C)CC=2C=C(OC)C(OC)=CC=2)=C1 CWMDTTATVCLRLI-UHFFFAOYSA-N 0.000 description 1
- SWLXYVFGYGNETA-UHFFFAOYSA-N 4-[3-[(3,4-dimethoxyphenyl)methyl-methylamino]propoxy]-2-methoxyaniline Chemical compound C1=C(N)C(OC)=CC(OCCCN(C)CC=2C=C(OC)C(OC)=CC=2)=C1 SWLXYVFGYGNETA-UHFFFAOYSA-N 0.000 description 1
- PLELZMLFJLNLOF-UHFFFAOYSA-N 4-[3-[(3,4-dimethoxyphenyl)methyl-methylamino]propoxy]-2-methylaniline Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)CCCOC1=CC=C(N)C(C)=C1 PLELZMLFJLNLOF-UHFFFAOYSA-N 0.000 description 1
- SNQYEMSDMWTCTI-UHFFFAOYSA-N 4-[3-[(3,4-dimethoxyphenyl)methyl-methylamino]propoxy]aniline Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)CCCOC1=CC=C(N)C=C1 SNQYEMSDMWTCTI-UHFFFAOYSA-N 0.000 description 1
- SGETUSPVZYEASR-UHFFFAOYSA-N 4-[3-[(3,4-dimethoxyphenyl)methyl-methylamino]propyl]-2-methylaniline Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)CCCC1=CC=C(N)C(C)=C1 SGETUSPVZYEASR-UHFFFAOYSA-N 0.000 description 1
- UCRGQRHPPKJIGF-UHFFFAOYSA-N 4-[3-[(3,4-dimethoxyphenyl)methyl-methylamino]propyl]aniline Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)CCCC1=CC=C(N)C=C1 UCRGQRHPPKJIGF-UHFFFAOYSA-N 0.000 description 1
- XSTJMUFNNIUSKR-UHFFFAOYSA-N 4-[3-[(3,4-dimethoxyphenyl)methyl-methylamino]propylsulfanyl]aniline Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)CCCSC1=CC=C(N)C=C1 XSTJMUFNNIUSKR-UHFFFAOYSA-N 0.000 description 1
- OXOSAPLQWKFPCM-UHFFFAOYSA-N 4-[3-[(4-methoxyphenyl)methyl-methylamino]propyl]aniline Chemical compound C1=CC(OC)=CC=C1CN(C)CCCC1=CC=C(N)C=C1 OXOSAPLQWKFPCM-UHFFFAOYSA-N 0.000 description 1
- VBAIORXXMFEWFZ-UHFFFAOYSA-N 4-[3-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]propoxy]aniline Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCOC1=CC=C(N)C=C1 VBAIORXXMFEWFZ-UHFFFAOYSA-N 0.000 description 1
- LDWOGAXSFBCVGA-UHFFFAOYSA-N 4-[3-[2-(4-methoxyphenyl)ethyl-methylamino]propoxy]aniline Chemical compound C1=CC(OC)=CC=C1CCN(C)CCCOC1=CC=C(N)C=C1 LDWOGAXSFBCVGA-UHFFFAOYSA-N 0.000 description 1
- KKEFCTVFANKRDQ-UHFFFAOYSA-N 4-[3-[methyl-[(3,4,5-trimethoxyphenyl)methyl]amino]propoxy]aniline Chemical compound COC1=C(OC)C(OC)=CC(CN(C)CCCOC=2C=CC(N)=CC=2)=C1 KKEFCTVFANKRDQ-UHFFFAOYSA-N 0.000 description 1
- JCPUIEJHSWQFEC-UHFFFAOYSA-N 4-[4-[(3,4-dimethoxyphenyl)methyl-methylamino]but-2-enyl]aniline Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)CC=CCC1=CC=C(N)C=C1 JCPUIEJHSWQFEC-UHFFFAOYSA-N 0.000 description 1
- YERUDYPVZNKMFH-UHFFFAOYSA-N 4-[4-[(3,4-dimethoxyphenyl)methyl-methylamino]butyl]aniline Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)CCCCC1=CC=C(N)C=C1 YERUDYPVZNKMFH-UHFFFAOYSA-N 0.000 description 1
- XUYWOJSJTLHJRO-UHFFFAOYSA-N 4-[4-[(4-fluorophenyl)methyl-methylamino]butyl]aniline Chemical compound C=1C=C(F)C=CC=1CN(C)CCCCC1=CC=C(N)C=C1 XUYWOJSJTLHJRO-UHFFFAOYSA-N 0.000 description 1
- XMSAKAXSAILLCT-UHFFFAOYSA-N 4-[4-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]butyl]aniline Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCCC1=CC=C(N)C=C1 XMSAKAXSAILLCT-UHFFFAOYSA-N 0.000 description 1
- NZZPPDRAEWDSJM-UHFFFAOYSA-N 4-[4-[2-(4-methoxyphenyl)ethyl-methylamino]butyl]aniline Chemical compound C1=CC(OC)=CC=C1CCN(C)CCCCC1=CC=C(N)C=C1 NZZPPDRAEWDSJM-UHFFFAOYSA-N 0.000 description 1
- QLCMGKJNOWBGGG-UHFFFAOYSA-N 4-[5-[(3,4-dimethoxyphenyl)methyl-methylamino]pentyl]aniline Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)CCCCCC1=CC=C(N)C=C1 QLCMGKJNOWBGGG-UHFFFAOYSA-N 0.000 description 1
- MMNMZFIWZBQPKA-UHFFFAOYSA-N 4-[[2-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)ethyl-methylamino]methyl]aniline Chemical compound C1C=2C=C(OC)C(OC)=CC=2CCN1CCN(C)CC1=CC=C(N)C=C1 MMNMZFIWZBQPKA-UHFFFAOYSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 description 1
- OLROGBNEPUZUGO-UHFFFAOYSA-N 4-n-[2-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)ethyl]benzene-1,4-diamine Chemical compound C1C=2C=C(OC)C(OC)=CC=2CCN1CCNC1=CC=C(N)C=C1 OLROGBNEPUZUGO-UHFFFAOYSA-N 0.000 description 1
- IFZGSWTWHPPCBI-UHFFFAOYSA-N 4-n-[2-[(3,4-dimethoxyphenyl)methyl-methylamino]ethyl]benzene-1,4-diamine Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)CCNC1=CC=C(N)C=C1 IFZGSWTWHPPCBI-UHFFFAOYSA-N 0.000 description 1
- PIIZYNQECPTVEO-UHFFFAOYSA-N 4-nitro-m-cresol Chemical compound CC1=CC(O)=CC=C1[N+]([O-])=O PIIZYNQECPTVEO-UHFFFAOYSA-N 0.000 description 1
- TYMLOMAKGOJONV-UHFFFAOYSA-N 4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1 TYMLOMAKGOJONV-UHFFFAOYSA-N 0.000 description 1
- OTLNPYWUJOZPPA-UHFFFAOYSA-N 4-nitrobenzoic acid Chemical compound OC(=O)C1=CC=C([N+]([O-])=O)C=C1 OTLNPYWUJOZPPA-UHFFFAOYSA-N 0.000 description 1
- KRSWPODJYNXIJP-UHFFFAOYSA-N 5,6-dimethoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound C1NCCC2=C(OC)C(OC)=CC=C21 KRSWPODJYNXIJP-UHFFFAOYSA-N 0.000 description 1
- SAKWPJNFGBWRFU-UHFFFAOYSA-N 5,7-dimethoxy-9-oxo-10h-acridine-4-carboxylic acid Chemical compound C1=CC=C2C(=O)C3=CC(OC)=CC(OC)=C3NC2=C1C(O)=O SAKWPJNFGBWRFU-UHFFFAOYSA-N 0.000 description 1
- ICWKCTNMYJHGIU-UHFFFAOYSA-N 5-(4-nitrophenyl)pentanoic acid Chemical compound OC(=O)CCCCC1=CC=C([N+]([O-])=O)C=C1 ICWKCTNMYJHGIU-UHFFFAOYSA-N 0.000 description 1
- JREIRAQRYBMGET-UHFFFAOYSA-N 5-[2-[(3,4-dimethoxyphenyl)methyl-methylamino]ethyl]-2-methoxyaniline Chemical compound C1=C(N)C(OC)=CC=C1CCN(C)CC1=CC=C(OC)C(OC)=C1 JREIRAQRYBMGET-UHFFFAOYSA-N 0.000 description 1
- GEVDRFBWKQEAEM-UHFFFAOYSA-N 6,7,8-trimethoxy-9-oxo-10H-acridine-4-carboxamide Chemical compound COC=1C=C2NC=3C(=CC=CC=3C(C2=C(C=1OC)OC)=O)C(=O)N GEVDRFBWKQEAEM-UHFFFAOYSA-N 0.000 description 1
- ZIEPQNJVJVBMTQ-UHFFFAOYSA-N 6,7,8-trimethoxy-9-oxo-10h-acridine-4-carboxylic acid Chemical compound N1C2=C(C(O)=O)C=CC=C2C(=O)C2=C1C=C(OC)C(OC)=C2OC ZIEPQNJVJVBMTQ-UHFFFAOYSA-N 0.000 description 1
- NWGTVQAKTBZZPT-UHFFFAOYSA-N 6,7-dimethoxy-2-[3-(3-methoxy-4-nitrophenoxy)propyl]-3,4-dihydro-1h-isoquinoline Chemical compound C1C=2C=C(OC)C(OC)=CC=2CCN1CCCOC1=CC=C([N+]([O-])=O)C(OC)=C1 NWGTVQAKTBZZPT-UHFFFAOYSA-N 0.000 description 1
- UFCFEFWPIQQEAS-UHFFFAOYSA-N 6,7-dimethoxy-2-[3-(3-methyl-4-nitrophenoxy)propyl]-3,4-dihydro-1h-isoquinoline Chemical compound C1C=2C=C(OC)C(OC)=CC=2CCN1CCCOC1=CC=C([N+]([O-])=O)C(C)=C1 UFCFEFWPIQQEAS-UHFFFAOYSA-N 0.000 description 1
- QEJSOKNMABMFNG-UHFFFAOYSA-N 6,7-dimethoxy-2-[3-(4-nitrophenoxy)propyl]-3,4-dihydro-1h-isoquinoline Chemical compound C1C=2C=C(OC)C(OC)=CC=2CCN1CCCOC1=CC=C([N+]([O-])=O)C=C1 QEJSOKNMABMFNG-UHFFFAOYSA-N 0.000 description 1
- CKRRTRHYZSEQEV-UHFFFAOYSA-N 6,7-dimethoxy-2-[3-(4-nitrophenyl)sulfanylpropyl]-3,4-dihydro-1h-isoquinoline Chemical compound C1C=2C=C(OC)C(OC)=CC=2CCN1CCCSC1=CC=C([N+]([O-])=O)C=C1 CKRRTRHYZSEQEV-UHFFFAOYSA-N 0.000 description 1
- WRDRTNPITYSFFP-UHFFFAOYSA-N 6,7-dimethoxy-2-[4-(4-nitrophenyl)butyl]-3,4-dihydro-1h-isoquinoline Chemical compound C1C=2C=C(OC)C(OC)=CC=2CCN1CCCCC1=CC=C([N+]([O-])=O)C=C1 WRDRTNPITYSFFP-UHFFFAOYSA-N 0.000 description 1
- YYTAYINRPUJPNH-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroisoquinoline Chemical compound C1NCCC2=CC(OC)=CC=C21 YYTAYINRPUJPNH-UHFFFAOYSA-N 0.000 description 1
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 1
- LGNJLFWLEGZOIC-UHFFFAOYSA-N 7-methylsulfanyl-9-oxo-10h-acridine-4-carboxylic acid Chemical compound C1=CC=C2C(=O)C3=CC(SC)=CC=C3NC2=C1C(O)=O LGNJLFWLEGZOIC-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- APCRFYGXPUAKFD-UHFFFAOYSA-N 82925-01-7 Chemical compound C1C=2C=C(OC)C(OC)=CC=2CCN1CCC1=CC=C([N+]([O-])=O)C=C1 APCRFYGXPUAKFD-UHFFFAOYSA-N 0.000 description 1
- XVQFALARZQSWRO-UHFFFAOYSA-N 9-oxo-1-phenyl-10H-acridine-4-carboxamide Chemical compound C1(=CC=CC=C1)C1=CC=C(C=2NC3=CC=CC=C3C(C1=2)=O)C(=O)N XVQFALARZQSWRO-UHFFFAOYSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- WNCZTZBFHICELG-UHFFFAOYSA-N C(C)(=O)N.C1NC=CC2=CC=CC=C12 Chemical compound C(C)(=O)N.C1NC=CC2=CC=CC=C12 WNCZTZBFHICELG-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- NHRTUNCCDBHLCP-UHFFFAOYSA-N CC1=C(C=CC(=C1)[N+](=O)[O-])CCCC(=O)N(C)C2=CC(=C(C=C2)OC)OC Chemical compound CC1=C(C=CC(=C1)[N+](=O)[O-])CCCC(=O)N(C)C2=CC(=C(C=C2)OC)OC NHRTUNCCDBHLCP-UHFFFAOYSA-N 0.000 description 1
- VGHPXYHNDLEATR-UHFFFAOYSA-N CCOC1=C(C=CC(=C1)C=CC(=O)C2CC3=CC(=C(C=C3CN2)OC)OC)[N+](=O)[O-] Chemical compound CCOC1=C(C=CC(=C1)C=CC(=O)C2CC3=CC(=C(C=C3CN2)OC)OC)[N+](=O)[O-] VGHPXYHNDLEATR-UHFFFAOYSA-N 0.000 description 1
- KONAWLRZCWFBHS-UHFFFAOYSA-N CN(CC1=CC=CC2=C1C3=CC=CC=C3C2)C(=O)CCCC4=CC=C(C=C4)N Chemical compound CN(CC1=CC=CC2=C1C3=CC=CC=C3C2)C(=O)CCCC4=CC=C(C=C4)N KONAWLRZCWFBHS-UHFFFAOYSA-N 0.000 description 1
- CDCTUIIEFKMHRN-UHFFFAOYSA-N CN(CCCOC1=CC=C(C=C1)[N+](=O)[O-])CC2=C(C=C(C=C2)OC)OC Chemical compound CN(CCCOC1=CC=C(C=C1)[N+](=O)[O-])CC2=C(C=C(C=C2)OC)OC CDCTUIIEFKMHRN-UHFFFAOYSA-N 0.000 description 1
- IZIRXASHPWMEII-UHFFFAOYSA-N CSC1=CC2=C(C=C1)NC3=C(C2=O)C=CC=C3C(=O)N Chemical compound CSC1=CC2=C(C=C1)NC3=C(C2=O)C=CC=C3C(=O)N IZIRXASHPWMEII-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229910021592 Copper(II) chloride Inorganic materials 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000792859 Enema Species 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- 108010026389 Gramicidin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 102220470425 Melanoregulin_H35N_mutation Human genes 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- FFKZOUIEAHOBHW-UHFFFAOYSA-N N,4-dimethyl-N-nitrosobenzenesulfonamide Chemical compound O=NN(C)S(=O)(=O)C1=CC=C(C)C=C1 FFKZOUIEAHOBHW-UHFFFAOYSA-N 0.000 description 1
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-diisopropylethylamine Substances CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- PVSNDWZOCSJKKX-UHFFFAOYSA-N N-[(3,4-dimethoxyphenyl)methyl]-N-methyl-3-(3-nitrophenoxy)propan-1-amine Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)CCCOC1=CC=CC([N+]([O-])=O)=C1 PVSNDWZOCSJKKX-UHFFFAOYSA-N 0.000 description 1
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 description 1
- 206010029260 Neuroblastoma Diseases 0.000 description 1
- ZBBHBTPTTSWHBA-UHFFFAOYSA-N Nicardipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)CC=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 ZBBHBTPTTSWHBA-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 102220513468 Rhophilin-2_H29N_mutation Human genes 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- USZYSDMBJDPRIF-SVEJIMAYSA-N aclacinomycin A Chemical compound O([C@H]1[C@@H](O)C[C@@H](O[C@H]1C)O[C@H]1[C@H](C[C@@H](O[C@H]1C)O[C@H]1C[C@]([C@@H](C2=CC=3C(=O)C4=CC=CC(O)=C4C(=O)C=3C(O)=C21)C(=O)OC)(O)CC)N(C)C)[C@H]1CCC(=O)[C@H](C)O1 USZYSDMBJDPRIF-SVEJIMAYSA-N 0.000 description 1
- 229960004176 aclarubicin Drugs 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- GOBKARNYNSWQFZ-UHFFFAOYSA-N anhalinine Chemical compound C1CNCC2=C1C=C(OC)C(OC)=C2OC GOBKARNYNSWQFZ-UHFFFAOYSA-N 0.000 description 1
- 239000003817 anthracycline antibiotic agent Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 125000005228 aryl sulfonate group Chemical group 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910000085 borane Inorganic materials 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- DLOZYAMHEPWUCN-UHFFFAOYSA-N bromoethane;nitrobenzene Chemical compound CCBr.[O-][N+](=O)C1=CC=CC=C1 DLOZYAMHEPWUCN-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- NDAYQJDHGXTBJL-MWWSRJDJSA-N chembl557217 Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](NC=O)C(C)C)CC(C)C)C(=O)NCCO)=CNC2=C1 NDAYQJDHGXTBJL-MWWSRJDJSA-N 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 1
- 229960000975 daunorubicin Drugs 0.000 description 1
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- MYTMXVHNEWBFAL-UHFFFAOYSA-L dipotassium;carbonate;hydrate Chemical compound O.[K+].[K+].[O-]C([O-])=O MYTMXVHNEWBFAL-UHFFFAOYSA-L 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000007920 enema Substances 0.000 description 1
- 229940079360 enema for constipation Drugs 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- PHRXNFRYTGJURS-UHFFFAOYSA-N ethyl 3-(3-hydroxy-4-nitrophenyl)prop-2-enoate Chemical compound CCOC(=O)C=CC1=CC=C([N+]([O-])=O)C(O)=C1 PHRXNFRYTGJURS-UHFFFAOYSA-N 0.000 description 1
- IRDRUDJDUCJCOS-UHFFFAOYSA-N ethyl 3-(3-methoxy-4-nitrophenyl)prop-2-enoate Chemical compound CCOC(=O)C=CC1=CC=C([N+]([O-])=O)C(OC)=C1 IRDRUDJDUCJCOS-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical class [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- UEXQBEVWFZKHNB-UHFFFAOYSA-N intermediate 29 Natural products C1=CC(N)=CC=C1NC1=NC=CC=N1 UEXQBEVWFZKHNB-UHFFFAOYSA-N 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-M methanesulfonate group Chemical class CS(=O)(=O)[O-] AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- JLKRJHPQNYVSGM-UHFFFAOYSA-N methyl-(4-nitro-benzyl)-amine Chemical compound CNCC1=CC=C([N+]([O-])=O)C=C1 JLKRJHPQNYVSGM-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- SYVQXWGIXIKGQS-UHFFFAOYSA-N n-(4-aminophenyl)-2-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)acetamide Chemical compound C1C=2C=C(OC)C(OC)=CC=2CCN1CC(=O)NC1=CC=C(N)C=C1 SYVQXWGIXIKGQS-UHFFFAOYSA-N 0.000 description 1
- PINVLHHHXXDLSA-UHFFFAOYSA-N n-(4-aminophenyl)-2-[(3,4-dimethoxyphenyl)methyl-methylamino]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)CC(=O)NC1=CC=C(N)C=C1 PINVLHHHXXDLSA-UHFFFAOYSA-N 0.000 description 1
- VIMPMSXLVQPHHY-UHFFFAOYSA-N n-[(3,4-dimethoxyphenyl)methyl]-2-(3-methoxy-4-nitrophenyl)-n-methylacetamide Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)C(=O)CC1=CC=C([N+]([O-])=O)C(OC)=C1 VIMPMSXLVQPHHY-UHFFFAOYSA-N 0.000 description 1
- ZPUIWGWEVRPGFI-UHFFFAOYSA-N n-[(3,4-dimethoxyphenyl)methyl]-2-(4-methoxy-3-nitrophenyl)-n-methylacetamide Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)C(=O)CC1=CC=C(OC)C([N+]([O-])=O)=C1 ZPUIWGWEVRPGFI-UHFFFAOYSA-N 0.000 description 1
- ZHYNRZUEWSOURD-UHFFFAOYSA-N n-[(3,4-dimethoxyphenyl)methyl]-3-(3-ethyl-4-nitrophenoxy)-n-methylpropan-1-amine Chemical compound C1=C([N+]([O-])=O)C(CC)=CC(OCCCN(C)CC=2C=C(OC)C(OC)=CC=2)=C1 ZHYNRZUEWSOURD-UHFFFAOYSA-N 0.000 description 1
- NPZAUZYHFMLEOA-UHFFFAOYSA-N n-[(3,4-dimethoxyphenyl)methyl]-3-(3-methoxy-4-nitrophenoxy)-n-methylpropan-1-amine Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)CCCOC1=CC=C([N+]([O-])=O)C(OC)=C1 NPZAUZYHFMLEOA-UHFFFAOYSA-N 0.000 description 1
- FCSOHMUDGKXIFA-UHFFFAOYSA-N n-[(3,4-dimethoxyphenyl)methyl]-n-methyl-2-(3-methyl-4-nitrophenoxy)ethanamine Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)CCOC1=CC=C([N+]([O-])=O)C(C)=C1 FCSOHMUDGKXIFA-UHFFFAOYSA-N 0.000 description 1
- PDSYEDGYHZKJKT-UHFFFAOYSA-N n-[(3,4-dimethoxyphenyl)methyl]-n-methyl-2-(3-nitrophenyl)ethanamine Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)CCC1=CC=CC([N+]([O-])=O)=C1 PDSYEDGYHZKJKT-UHFFFAOYSA-N 0.000 description 1
- HRPWMKHJUHUCAQ-UHFFFAOYSA-N n-[(3,4-dimethoxyphenyl)methyl]-n-methyl-2-(4-nitrophenoxy)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)C(=O)COC1=CC=C([N+]([O-])=O)C=C1 HRPWMKHJUHUCAQ-UHFFFAOYSA-N 0.000 description 1
- XPIUQFSCLSVXQR-UHFFFAOYSA-N n-[(3,4-dimethoxyphenyl)methyl]-n-methyl-2-(4-nitrophenyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)C(=O)CC1=CC=C([N+]([O-])=O)C=C1 XPIUQFSCLSVXQR-UHFFFAOYSA-N 0.000 description 1
- JBTOHCUYLYRCPP-UHFFFAOYSA-N n-[(3,4-dimethoxyphenyl)methyl]-n-methyl-3-(3-methyl-4-nitrophenoxy)propan-1-amine Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)CCCOC1=CC=C([N+]([O-])=O)C(C)=C1 JBTOHCUYLYRCPP-UHFFFAOYSA-N 0.000 description 1
- SEZTVPKDZMRPOX-UHFFFAOYSA-N n-[(3,4-dimethoxyphenyl)methyl]-n-methyl-3-(3-methyl-4-nitrophenyl)propanamide Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)C(=O)CCC1=CC=C([N+]([O-])=O)C(C)=C1 SEZTVPKDZMRPOX-UHFFFAOYSA-N 0.000 description 1
- WUSKNZFPEOCHSB-UHFFFAOYSA-N n-[(3,4-dimethoxyphenyl)methyl]-n-methyl-3-(3-nitrophenyl)prop-2-enamide Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)C(=O)C=CC1=CC=CC([N+]([O-])=O)=C1 WUSKNZFPEOCHSB-UHFFFAOYSA-N 0.000 description 1
- GHNQPNPEXMDDJS-UHFFFAOYSA-N n-[(3,4-dimethoxyphenyl)methyl]-n-methyl-3-(4-nitrophenyl)prop-2-en-1-amine Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)CC=CC1=CC=C([N+]([O-])=O)C=C1 GHNQPNPEXMDDJS-UHFFFAOYSA-N 0.000 description 1
- RUZLGVDTRNCUFJ-UHFFFAOYSA-N n-[(3,4-dimethoxyphenyl)methyl]-n-methyl-3-(4-nitrophenyl)propanamide Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)C(=O)CCC1=CC=C([N+]([O-])=O)C=C1 RUZLGVDTRNCUFJ-UHFFFAOYSA-N 0.000 description 1
- FDSBJZKABICGIT-UHFFFAOYSA-N n-[(3,4-dimethoxyphenyl)methyl]-n-methyl-3-(4-nitrophenyl)sulfanylpropan-1-amine Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)CCCSC1=CC=C([N+]([O-])=O)C=C1 FDSBJZKABICGIT-UHFFFAOYSA-N 0.000 description 1
- WXZYDRAQUSVYTA-UHFFFAOYSA-N n-[(3,4-dimethoxyphenyl)methyl]-n-methyl-4-(4-nitrophenyl)but-2-en-1-amine Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)CC=CCC1=CC=C([N+]([O-])=O)C=C1 WXZYDRAQUSVYTA-UHFFFAOYSA-N 0.000 description 1
- SREOZSXXAWTODL-UHFFFAOYSA-N n-[(3,4-dimethoxyphenyl)methyl]-n-methyl-5-(4-nitrophenyl)pentanamide Chemical compound C1=C(OC)C(OC)=CC=C1CN(C)C(=O)CCCCC1=CC=C([N+]([O-])=O)C=C1 SREOZSXXAWTODL-UHFFFAOYSA-N 0.000 description 1
- OFZYCRSZFBBHAF-UHFFFAOYSA-N n-[(4-fluorophenyl)methyl]-n-methyl-4-(4-nitrophenyl)butanamide Chemical compound C=1C=C([N+]([O-])=O)C=CC=1CCCC(=O)N(C)CC1=CC=C(F)C=C1 OFZYCRSZFBBHAF-UHFFFAOYSA-N 0.000 description 1
- OOUMTRLJILMXIN-UHFFFAOYSA-N n-[(4-methoxyphenyl)methyl]-n-methyl-2-(4-nitrophenoxy)acetamide Chemical compound C1=CC(OC)=CC=C1CN(C)C(=O)COC1=CC=C([N+]([O-])=O)C=C1 OOUMTRLJILMXIN-UHFFFAOYSA-N 0.000 description 1
- AJVNCLXMMCKDSP-UHFFFAOYSA-N n-[(4-methoxyphenyl)methyl]-n-methyl-3-(4-nitrophenyl)propanamide Chemical compound C1=CC(OC)=CC=C1CN(C)C(=O)CCC1=CC=C([N+]([O-])=O)C=C1 AJVNCLXMMCKDSP-UHFFFAOYSA-N 0.000 description 1
- UMYBMLOSSYMDMZ-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methyl-2-(4-nitrophenoxy)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)C(=O)COC1=CC=C([N+]([O-])=O)C=C1 UMYBMLOSSYMDMZ-UHFFFAOYSA-N 0.000 description 1
- VFQREOSSGZIDHJ-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methyl-2-(4-nitrophenyl)acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)C(=O)CC1=CC=C([N+]([O-])=O)C=C1 VFQREOSSGZIDHJ-UHFFFAOYSA-N 0.000 description 1
- ANBPCXLKGLGJQI-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methyl-3-(4-nitrophenoxy)propan-1-amine Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCOC1=CC=C([N+]([O-])=O)C=C1 ANBPCXLKGLGJQI-UHFFFAOYSA-N 0.000 description 1
- SQSKSIACYYELDF-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-n-methyl-4-(4-nitrophenyl)butanamide Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)C(=O)CCCC1=CC=C([N+]([O-])=O)C=C1 SQSKSIACYYELDF-UHFFFAOYSA-N 0.000 description 1
- UEBKJUMGYQAIHO-UHFFFAOYSA-N n-[2-(4-methoxyphenyl)ethyl]-n-methyl-2-(4-nitrophenoxy)acetamide Chemical compound C1=CC(OC)=CC=C1CCN(C)C(=O)COC1=CC=C([N+]([O-])=O)C=C1 UEBKJUMGYQAIHO-UHFFFAOYSA-N 0.000 description 1
- URWDLVAUJXVWND-UHFFFAOYSA-N n-[2-(4-methoxyphenyl)ethyl]-n-methyl-2-(4-nitrophenyl)acetamide Chemical compound C1=CC(OC)=CC=C1CCN(C)C(=O)CC1=CC=C([N+]([O-])=O)C=C1 URWDLVAUJXVWND-UHFFFAOYSA-N 0.000 description 1
- CSLOTJQHCBCQOF-UHFFFAOYSA-N n-[2-(4-methoxyphenyl)ethyl]-n-methyl-3-(4-nitrophenoxy)propan-1-amine Chemical compound C1=CC(OC)=CC=C1CCN(C)CCCOC1=CC=C([N+]([O-])=O)C=C1 CSLOTJQHCBCQOF-UHFFFAOYSA-N 0.000 description 1
- UVJZLMNQMNMPSI-UHFFFAOYSA-N n-[2-(4-methoxyphenyl)ethyl]-n-methyl-4-(4-nitrophenyl)butanamide Chemical compound C1=CC(OC)=CC=C1CCN(C)C(=O)CCCC1=CC=C([N+]([O-])=O)C=C1 UVJZLMNQMNMPSI-UHFFFAOYSA-N 0.000 description 1
- YRVYLGUHKHYLOI-UHFFFAOYSA-N n-[3-[2-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)ethyl]phenyl]-5-fluoro-9-oxo-10h-acridine-4-carboxamide Chemical compound N1C2=C(F)C=CC=C2C(=O)C2=C1C(C(=O)NC=1C=CC=C(C=1)CCN1CCC=3C=C(C(=CC=3C1)OC)OC)=CC=C2 YRVYLGUHKHYLOI-UHFFFAOYSA-N 0.000 description 1
- URQXQWYNIQQOOO-UHFFFAOYSA-N n-[3-[3-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)propyl]phenyl]-5-methoxy-9-oxo-10h-acridine-4-carboxamide Chemical compound C1=CC(OC)=C2N=C3C(C(=O)NC=4C=CC=C(C=4)CCCN4CCC=5C=C(C(=CC=5C4)OC)OC)=CC=CC3=C(O)C2=C1 URQXQWYNIQQOOO-UHFFFAOYSA-N 0.000 description 1
- OBEOFOYQOPKYFV-UHFFFAOYSA-N n-[4-(3-bromopropoxy)phenyl]-9-oxo-10h-acridine-4-carboxamide Chemical compound C1=CC(OCCCBr)=CC=C1NC(=O)C1=CC=CC2=C1NC1=CC=CC=C1C2=O OBEOFOYQOPKYFV-UHFFFAOYSA-N 0.000 description 1
- GYQVTCSDOJTHEB-UHFFFAOYSA-N n-[4-(3-bromopropoxy)phenyl]acetamide Chemical compound CC(=O)NC1=CC=C(OCCCBr)C=C1 GYQVTCSDOJTHEB-UHFFFAOYSA-N 0.000 description 1
- ZUWUJLQQRMQLKX-UHFFFAOYSA-N n-[4-[2-(5,6-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)ethyl]phenyl]-5-methoxy-9-oxo-10h-acridine-4-carboxamide Chemical compound N1C2=C(OC)C=CC=C2C(=O)C2=C1C(C(=O)NC1=CC=C(C=C1)CCN1CC3=CC=C(C(=C3CC1)OC)OC)=CC=C2 ZUWUJLQQRMQLKX-UHFFFAOYSA-N 0.000 description 1
- FKEMJSQZKFCUDK-UHFFFAOYSA-N n-[4-[2-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)ethyl]-2-methylphenyl]-5-fluoro-9-oxo-10h-acridine-4-carboxamide Chemical compound N1C2=C(F)C=CC=C2C(=O)C2=C1C(C(=O)NC1=CC=C(C=C1C)CCN1CCC=3C=C(C(=CC=3C1)OC)OC)=CC=C2 FKEMJSQZKFCUDK-UHFFFAOYSA-N 0.000 description 1
- RBSRJRFUKKGKSK-UHFFFAOYSA-N n-oxoacridine-4-carboxamide Chemical compound C1=CC=C2N=C3C(C(=O)N=O)=CC=CC3=CC2=C1 RBSRJRFUKKGKSK-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229960001783 nicardipine Drugs 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 239000002687 nonaqueous vehicle Substances 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- VMPITZXILSNTON-UHFFFAOYSA-N o-anisidine Chemical compound COC1=CC=CC=C1N VMPITZXILSNTON-UHFFFAOYSA-N 0.000 description 1
- 239000007935 oral tablet Substances 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- GEVPUGOOGXGPIO-UHFFFAOYSA-N oxalic acid;dihydrate Chemical compound O.O.OC(=O)C(O)=O GEVPUGOOGXGPIO-UHFFFAOYSA-N 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- AYKOTYRPPUMHMT-UHFFFAOYSA-N silver;hydrate Chemical compound O.[Ag] AYKOTYRPPUMHMT-UHFFFAOYSA-N 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 150000003890 succinate salts Chemical class 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- 229940063683 taxotere Drugs 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical class CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229960003048 vinblastine Drugs 0.000 description 1
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 description 1
- 229960002066 vinorelbine Drugs 0.000 description 1
- GBABOYUKABKIAF-GHYRFKGUSA-N vinorelbine Chemical compound C1N(CC=2C3=CC=CC=C3NC=22)CC(CC)=C[C@H]1C[C@]2(C(=O)OC)C1=CC([C@]23[C@H]([C@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC GBABOYUKABKIAF-GHYRFKGUSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
- C07C205/11—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/13—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
- C07C205/26—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups and being further substituted by halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
- C07C205/35—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/36—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
- C07C205/37—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/06—Oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Dry Shavers And Clippers (AREA)
- Laminated Bodies (AREA)
- Soft Magnetic Materials (AREA)
- Paper (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919100637A GB9100637D0 (en) | 1991-01-11 | 1991-01-11 | Chemical compounds |
| GB919100628A GB9100628D0 (en) | 1991-01-11 | 1991-01-11 | Chemical compounds |
| GB919115981A GB9115981D0 (en) | 1991-07-24 | 1991-07-24 | Chemical compounds |
| GB919115956A GB9115956D0 (en) | 1991-07-24 | 1991-07-24 | Chemical compounds |
| PCT/EP1992/000020 WO1992012132A1 (en) | 1991-01-11 | 1992-01-07 | Acridine derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK73093A3 SK73093A3 (en) | 1994-01-12 |
| SK280864B6 true SK280864B6 (en) | 2000-08-14 |
Family
ID=27450605
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK730-93A SK280864B6 (en) | 1991-01-11 | 1992-01-07 | Acridine derivatives, process for their preparation, and pharmaceutical compositions based thereon |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US5604237A (cs) |
| EP (2) | EP0494623A1 (cs) |
| JP (1) | JP2783680B2 (cs) |
| KR (1) | KR100220538B1 (cs) |
| AT (1) | ATE153660T1 (cs) |
| AU (1) | AU652996B2 (cs) |
| CA (1) | CA2100258C (cs) |
| CZ (1) | CZ283038B6 (cs) |
| DE (1) | DE69220037T2 (cs) |
| DK (1) | DK0569380T3 (cs) |
| ES (1) | ES2104887T3 (cs) |
| FI (1) | FI103888B1 (cs) |
| GE (1) | GEP20002210B (cs) |
| GR (1) | GR3024525T3 (cs) |
| HU (2) | HUT68856A (cs) |
| IE (1) | IE920083A1 (cs) |
| IL (1) | IL100631A (cs) |
| MX (1) | MX9200109A (cs) |
| NO (1) | NO300267B1 (cs) |
| NZ (1) | NZ241278A (cs) |
| PL (1) | PL168202B1 (cs) |
| RU (1) | RU2119482C1 (cs) |
| SG (1) | SG45403A1 (cs) |
| SK (1) | SK280864B6 (cs) |
| WO (1) | WO1992012132A1 (cs) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ283038B6 (cs) * | 1991-01-11 | 1997-12-17 | Laboratoires Glaxo Sa | Akridinové deriváty, způsob výroby a farmaceutické prostředky s jejich obsahem |
| GB9209872D0 (en) * | 1992-05-07 | 1992-06-24 | Ici Plc | Alkyl substituted nitrotoluene derivatives |
| TR28930A (tr) * | 1992-05-07 | 1997-07-21 | Zeneca Ltd | Alkil sübstitüentli nitrotoluen türevleri |
| ES2103479T3 (es) * | 1992-07-10 | 1997-09-16 | Glaxo Lab Sa | Derivados de anilida. |
| RU2036198C1 (ru) * | 1993-04-01 | 1995-05-27 | Товарищество с ограниченной ответственностью "Полисан" | N-МЕТИЛ-N-( α,D -ГЛЮКОПИРАНОЗИЛ) АММОНИЯ-2-(АКРИДОН-9-ОН-10-ИЛ)АЦЕТАТ(ЦИКЛОФЕРОН), ОБЛАДАЮЩИЙ ИНТЕРФЕРОНОГЕННОЙ, ПРОТИВОВИРУСНОЙ, В ТОМ ЧИСЛЕ АНТИВИЧ, АНТИПАРАЗИТАРНОЙ, АНТИПРОМОТОРНОЙ И РАДИОПРОТЕКТИВНОЙ АКТИВНОСТЬЮ |
| US5387685A (en) * | 1993-07-16 | 1995-02-07 | American Cyanamid Co | MDR reversal agents |
| DE4422517A1 (de) * | 1994-06-28 | 1996-01-04 | Dresden Arzneimittel | Neue (2-(3,4-Dimethoxy-phenyl)-ethyl)-(2-phenoxy-ethyl)-amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| CN1134410C (zh) * | 1994-08-04 | 2004-01-14 | C&C新药研究所 | 胺衍生物,制备它们的方法和它们作为抗心律失常药的应用 |
| AU702519B2 (en) * | 1994-10-05 | 1999-02-25 | Glaxo Wellcome Inc. | Parenteral pharmaceutical compositions containing GF120918A |
| FR2726267B1 (fr) * | 1994-10-26 | 1998-01-02 | Smithkline Beecham Lab | Nouveaux agents anti-arythmiques, compositions pharmaceutiques les contenant, et procede pour les preparer |
| US6395770B1 (en) | 1995-10-26 | 2002-05-28 | Baker Norton Pharmaceuticals, Inc. | Method and compositions for administering taxanes orally to human patients |
| US6245805B1 (en) | 1995-10-26 | 2001-06-12 | Baker Norton Pharmaceuticals, Inc. | Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| WO1997028166A1 (de) * | 1996-02-01 | 1997-08-07 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Thienochinoline |
| US6713517B1 (en) | 1996-03-08 | 2004-03-30 | Oxigene, Inc. | Use of aryl N-substituted carboxamides directly and as radio-and chemosensitizers for killing tumor and cancer cells and novel compounds for such use |
| RU2118532C1 (ru) * | 1996-04-10 | 1998-09-10 | Олег Викторович Травкин | Противоинфекционное, противовоспалительное и противоопухолевое лекарственное средство |
| GB2333293B (en) * | 1996-10-18 | 2000-07-12 | Xenova Ltd | Process for the preparation of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide used as anti cancer compounds |
| MY118642A (en) * | 1996-10-18 | 2004-12-31 | Xenova Ltd | Anthranilic acid derivatives as multi drug resistance modulators |
| GB9708805D0 (en) | 1997-05-01 | 1997-06-25 | Smithkline Beecham Plc | Compounds |
| GB9710612D0 (en) * | 1997-05-23 | 1997-07-16 | Glaxo Group Ltd | Synthesis of acridine derivatives |
| DK0994706T3 (da) * | 1997-05-27 | 2006-03-06 | Ivax Research Inc | Præparater til oral indgivelse af taxaner og anvendelse deraf |
| GB9718903D0 (en) * | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| GB9810876D0 (en) | 1998-05-20 | 1998-07-22 | Smithkline Beecham Plc | Compounds |
| GB9812189D0 (en) * | 1998-06-05 | 1998-08-05 | Glaxo Group Ltd | Methods and compositions for increasing penetration of HIV protease inhibitors |
| AU4698299A (en) * | 1998-06-30 | 2000-01-17 | Du Pont Pharmaceuticals Company | 5-HT7 receptor antagonists |
| RU2135474C1 (ru) * | 1998-08-19 | 1999-08-27 | Травкин Олег Викторович | Соли 1-дезокси-1-n-метиламиногексаспиртов с n-акридонуксусной кислотой, обладающие иммуномодулирующей активностью, и лекарственное средство на их основе |
| SK4782001A3 (en) | 1998-10-08 | 2001-11-06 | Smithkline Beecham Plc | Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| GB9824579D0 (en) * | 1998-11-10 | 1999-01-06 | Novartis Ag | Organic compounds |
| EP1749540B1 (en) * | 1999-05-17 | 2010-10-13 | Cancer Research Ventures Limited | Compositions for improving bioavailability of orally administered drugs |
| EP2266607A3 (en) | 1999-10-01 | 2011-04-20 | Immunogen, Inc. | Immunoconjugates for treating cancer |
| US6521635B1 (en) | 2000-01-20 | 2003-02-18 | The United States Of America As Represented By The Department Of Health And Human Services | Inhibition of MXR transport by acridine derivatives |
| AU2001238499A1 (en) | 2000-02-18 | 2001-08-27 | New York Medical College | Nitroacridine/tumor inhibitor compositions |
| KR100842698B1 (ko) * | 2000-03-14 | 2008-07-01 | 액테리온 파마슈티칼 리미티드 | 1,2,3,4-테트라하이드로이소퀴놀린 유도체 |
| AU779266B2 (en) | 2000-05-11 | 2005-01-13 | Banyu Pharmaceutical Co., Ltd. | N-acyltetrahydroisoquinoline derivatives |
| CN1469735A (zh) * | 2000-10-16 | 2004-01-21 | ����˹��ҩ�﹫˾ | 米托蒽醌的脂质体制剂 |
| KR101060971B1 (ko) * | 2002-05-14 | 2011-09-01 | 제노바 리미티드 | 안트라닐산 유도체 수화물의 제조 방법 |
| RU2279873C2 (ru) * | 2002-05-31 | 2006-07-20 | Ар.Пи.ШЕРЕР ТЕКНОЛОДЖИЗ, ИНК. | Пероральная фармацевтическая композиция для мягких капсул, содержащая винорелбин, и способ лечения |
| WO2004039795A2 (en) * | 2002-10-29 | 2004-05-13 | Fujisawa Pharmaceutical Co., Ltd. | Amide compounds for the treatment of hyperlipidemia |
| DK1751111T3 (en) | 2004-03-01 | 2015-02-09 | Actelion Pharmaceuticals Ltd | SUBSTITUTED 1,2,3,4-tetrahydroisoquinoline derivatives |
| RU2326115C2 (ru) * | 2005-11-21 | 2008-06-10 | Ефаг АО | Соли 1-алкиламино-1-дезоксиполиолов с 9-оксоакридин-10-уксусной кислотой, лекарственные препараты на их основе, применение, способы профилактики и лечения |
| ES2431564T3 (es) * | 2006-03-22 | 2013-11-27 | Janssen Pharmaceutica N.V. | Inhibidores de la interacción entre MDM2 y p53 |
| RU2346692C2 (ru) * | 2007-03-29 | 2009-02-20 | Ефаг АО | Применение 9-оксоакридин-10-уксусной кислоты, ее солей и сложных эфиров в комбинированной терапии рака яичников, способ лечения и наборы |
| RU2346691C2 (ru) * | 2007-03-29 | 2009-02-20 | Ефаг АО | Применение 9-оксоакридин-10-уксусной кислоты и/или ее соли в комбинации с антиэстрогеном и/или прогестином для лечения эстрогензависимых опухолей, способ лечения и наборы |
| SE531698C2 (sv) * | 2007-07-12 | 2009-07-07 | Respiratorius Ab | Nya bronkdilaterande a,b-omättade amider |
| WO2015142670A1 (en) * | 2014-03-15 | 2015-09-24 | Medisyn Technologies, Inc. | Anti-diabetic compounds, pharmaceutical compositions containing them, and method to treat diabetes |
| CN104434808A (zh) | 2014-07-03 | 2015-03-25 | 石药集团中奇制药技术(石家庄)有限公司 | 一种治疗性纳米粒子及其制备方法 |
| CN111867577A (zh) * | 2018-03-21 | 2020-10-30 | 艾祖米科技有限公司 | 依克立达的氘化类似物 |
| CN113387873B (zh) * | 2021-06-15 | 2022-09-20 | 山东第一医科大学(山东省医学科学院) | 取代二芳基类化合物其制备方法和用途 |
| CN115252613B (zh) * | 2022-08-09 | 2024-01-12 | 北京清华长庚医院 | 药物组合物及其在逆转仑伐替尼耐药性中的用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4250182A (en) * | 1972-02-24 | 1981-02-10 | Burroughs Wellcome Co. | Pharmaceutical composition containing acridone compounds and method of using same |
| US4021551A (en) * | 1972-06-07 | 1977-05-03 | Boehringer Ingelheim Gmbh | 3,6-Bis-(heterocyclic aminoacyl-amino)-acridines and salts thereof |
| US4127573A (en) * | 1972-09-06 | 1978-11-28 | Burroughs Wellcome Co. | Ditetrazole substituted acridone compounds |
| DE3170001D1 (en) * | 1980-09-30 | 1985-05-23 | Bayer Ag | Method for the production of an antithrombin-heparin complex and pharmaceutical compositions containing the complex |
| NZ198115A (en) * | 1981-08-21 | 1985-05-31 | New Zealand Dev Finance | 9-anilinoacridines;pharmaceutical compositions |
| NZ201084A (en) * | 1982-06-25 | 1985-10-11 | New Zealand Dev Finance | 4-carboxamidoacridine derivatives and pharmaceutical compositions containing such |
| IN164921B (cs) * | 1986-07-22 | 1989-07-08 | Hoechst India | |
| US5104858A (en) * | 1988-09-29 | 1992-04-14 | Yale University | Sensitizing multidrug resistant cells to antitumor agents |
| CA1340821C (en) * | 1988-10-06 | 1999-11-16 | Nobuyuki Fukazawa | Heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components |
| JPH04506072A (ja) * | 1989-06-19 | 1992-10-22 | ザ・ウエルカム・ファウンデーション・リミテッド | 癌治療に有用であり、かつ抗ヒスタミン特性を有する医薬 |
| CZ283038B6 (cs) * | 1991-01-11 | 1997-12-17 | Laboratoires Glaxo Sa | Akridinové deriváty, způsob výroby a farmaceutické prostředky s jejich obsahem |
| US5296602A (en) * | 1991-03-18 | 1994-03-22 | Sloan-Kettering Institute For Cancer Research | Multisubstituted 1-hydroxy-9-acridones with anticancer activity |
| US5240936A (en) * | 1992-05-14 | 1993-08-31 | Texas A&M University System | Treating or preventing ocular inflammation or systemic imflammatory disease |
-
1992
- 1992-01-07 CZ CS931378A patent/CZ283038B6/cs not_active IP Right Cessation
- 1992-01-07 KR KR1019930702079A patent/KR100220538B1/ko not_active Expired - Lifetime
- 1992-01-07 AT AT92901861T patent/ATE153660T1/de not_active IP Right Cessation
- 1992-01-07 PL PL92299989A patent/PL168202B1/pl unknown
- 1992-01-07 SG SG1996006197A patent/SG45403A1/en unknown
- 1992-01-07 EP EP92100123A patent/EP0494623A1/en active Pending
- 1992-01-07 JP JP4501671A patent/JP2783680B2/ja not_active Expired - Lifetime
- 1992-01-07 CA CA002100258A patent/CA2100258C/en not_active Expired - Lifetime
- 1992-01-07 HU HU9301989A patent/HUT68856A/hu unknown
- 1992-01-07 WO PCT/EP1992/000020 patent/WO1992012132A1/en not_active Ceased
- 1992-01-07 EP EP92901861A patent/EP0569380B1/en not_active Expired - Lifetime
- 1992-01-07 DE DE69220037T patent/DE69220037T2/de not_active Expired - Lifetime
- 1992-01-07 GE GEAP19922653A patent/GEP20002210B/en unknown
- 1992-01-07 DK DK92901861.2T patent/DK0569380T3/da active
- 1992-01-07 RU RU93051543A patent/RU2119482C1/ru active
- 1992-01-07 AU AU11543/92A patent/AU652996B2/en not_active Expired
- 1992-01-07 ES ES92901861T patent/ES2104887T3/es not_active Expired - Lifetime
- 1992-01-07 SK SK730-93A patent/SK280864B6/sk not_active IP Right Cessation
- 1992-01-10 NZ NZ241278A patent/NZ241278A/en not_active IP Right Cessation
- 1992-01-10 MX MX9200109A patent/MX9200109A/es unknown
- 1992-01-10 IL IL10063192A patent/IL100631A/en not_active IP Right Cessation
- 1992-01-10 IE IE008392A patent/IE920083A1/en not_active IP Right Cessation
-
1993
- 1993-07-09 FI FI933149A patent/FI103888B1/fi active
- 1993-07-09 NO NO932512A patent/NO300267B1/no not_active IP Right Cessation
-
1995
- 1995-06-06 US US08/468,620 patent/US5604237A/en not_active Expired - Lifetime
- 1995-06-29 HU HU95P/P00524P patent/HU211623A9/hu unknown
-
1997
- 1997-08-22 GR GR970402168T patent/GR3024525T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK280864B6 (en) | Acridine derivatives, process for their preparation, and pharmaceutical compositions based thereon | |
| US5663179A (en) | Certain isoquinoline derivatives having anti-tumor properties | |
| JP5057273B2 (ja) | イソインドリン−1−ワン誘導体 | |
| ES2210586T3 (es) | Derivados de acido antranilico como moduladores de la multiresistencia a farmacos. | |
| ES2210524T3 (es) | Derivados de chalcona y medicamentos que los contienen. | |
| EA005761B1 (ru) | 4-аминозамещенные-2-замещенные-1,2,3,4-тетрагидрохинолины в качестве ингибиторов сетр (хэпб) | |
| JP4108129B2 (ja) | Eaaアンタゴニストとしてのテトラヒドロキノリン誘導体 | |
| GB2163426A (en) | Substituted quinazolinones having functionality at n1 | |
| SK29699A3 (en) | Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect | |
| US4381398A (en) | Amino-alcohol derivatives | |
| EP0855387A1 (en) | 2-acylaminobenzamide derivatives and preventive and remedy for diseases caused by the supermultiplication of vascular intimal cells | |
| EP0538477B1 (en) | Novel cyclic aminophenylacetic acid derivative, production thereof, and immune response modulator containing the same as active ingredient | |
| RU2195454C2 (ru) | Производные антраниловой кислоты, способы их получения и фармацевтическая композиция на их основе | |
| JPS6299352A (ja) | 1,1,2−トリフエニル−1−ブテン誘導体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4A | Patent expired |
Expiry date: 20120107 |